Anubhav Sahu Moneycontrol Research - Strong HCQS sales in Q1 FY21 though uncertainty increases for future demand - Strong operating performance and guidance brings focus beyond HCQS - FY21 guidance for 15% plus sales growth and margin expansion of 150 bps - Resolution of US FDA import alerts and environment clearances - key near term watch IPCA Labs (CMP: Rs 1,662, Market cap: Rs 21,008 crore) had been on the radar of investors as the anti-malarial drug HCQS (hydroxychloroquine sulphate) was seen as a drug of choice...
Moneycontrol Pro Panorama | MPC plays it safe, more rate hikes coming?
Feb 8, 2023 / 03:17 PM IST
In today’s edition of Moneycontrol Pro Panorama: No end to rate hike cycle, make the most of market volatility, puzzling economi...Read Now
Moneycontrol Pro Weekender: The elephant in the room
Feb 4, 2023 / 11:20 AM IST
The well-crafted and well-delivered budget got many ‘wows’, but Mr Market’s worry lines are not yet goneRead Now
To read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Access to 230+ exclusive stories per month from our editorial and Experts
Have a Global edge with access to content from world renowned experts and journalist
Access to 40+ weekly investment ideas including 4 daily technical calls
Exclusive access to live webinars from market experts on trading and investment strategies
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers